Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Bupivacaine Dose for Labor Epidural Pain Relief
NCT06146842Phase 4Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Dec 2023
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in labor pain (2 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Numerical Rating Scale < 3 at 30 months. Started Dec 2023; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
labor pain
Beyond the preview
Go deeper on NCT06146842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06146842.